Loading...
XNAS
ZTEK
Market cap51mUSD
Jul 09, Last price  
0.47USD
1D
-1.85%
1Q
-13.86%
Jan 2017
-26.18%
IPO
45.82%
Name

Zentek Ltd

Chart & Performance

D1W1MN
XNAS:ZTEK chart
P/E
P/S
431.13
EPS
Div Yield, %
Shrs. gr., 5y
4.74%
Rev. gr., 5y
134.35%
Revenues
166k
-80.92%
000000000002,355339,66672,85529,816872,495166,476
Net income
-10m
L-2.45%
-147,951-1,242,022-1,039,298-2,351,960-3,524,807-3,015,706-4,197,806-2,840,621-1,564,521-2,428,153-1,082,570-3,868,650-31,694,048-14,414,266-11,703,990-10,039,658-9,793,200
CFO
0k
P
-37,741-1,084,560-1,317,792-1,640,185-2,385,803-1,246,360-1,681,810-1,710,072-999,855-1,183,545-1,356,386-1,794,683-7,988,872-12,956,870-5,943,682-6,282,4410

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zentek Ltd. is a Canadian company focused on the exploration and advancement of graphene and related nanomaterials. It fully owns the Albany Graphite project, situated in Northern Ontario, Canada. The firm develops its ZenGUARD brand, a graphene-based antimicrobial coating, incorporating it into products like surgical masks, HVAC filters, and personal protective equipment. Additionally, Zentek's innovation extends to rapid detection point-of-care diagnostics and pharmaceutical products, all leveraging graphene-based compounds. The company also specializes in synthesizing graphene, graphene oxide, and graphene quantum dots for diverse applications. Founded in 2008 and headquartered in Thunder Bay, Canada, Zentek Ltd. was formerly known as ZEN Graphene Solutions Ltd. until its name change in October 2021.
IPO date
Dec 22, 2010
Employees
29
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT